Benuvia Therapeutics Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2019

Location

Chandler AZ US

Primary Industry

Biotechnology

About

Based in Arizona, US and founded in 2019, Benuvia Therapeutics Inc. develops cannabinoid drugs for patients suffering from migraine, schizophrenia, erectile dysfunction, opioid withdrawal, and anxiety. The company works with pharmaceutical institutions, by developing cannabinoid drugs to help patients ease moderate to severe pain, opioid withdrawal, migraine, anxiety attack, and schizophrenia. The firm offers these drugs to pharmaceutical companies for commercialization, enabling them to sell in drug stores. The company's revenue is generated by selling these cannabis-based medicines. The pharmaceutical companies will approach the biopharmaceutical company for product commercialization, buying their patented products focused on patients with mental illness or disorder, before selling them to the public. The company will also show their on-going research studies intended to develop medicine for anxiety disorder, management of psychotic disorders, bipolar, and acute migraine for future negotiations. In 2021, Benuvia Therapeutics Inc.’s synthetic cannabidiol oral solution was acquired by Radius Health, Inc., a biopharmaceutical company that develops drug therapies for patients with osteoporosis and breast cancer. The acquisition will help the company to fund existing operations such as product research and development.

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Mental Health Services, Pharmaceutical Research & Development

Website

www.benuvia.com

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.